logo
A Child's BMI At This Age Can Predict If They Will Be Obese As Adult

A Child's BMI At This Age Can Predict If They Will Be Obese As Adult

NDTV12-05-2025

The body mass index (BMI) of a child at the age of six is the best predictor of whether they will be obese in adulthood, a new study has claimed. Academics from the Netherlands said the first five years were critical in preventing weight gain in later years.
The researchers used data from a study known as Generation R to track the BMI of 3,528 children in the Netherlands at ages two, six, 10, 14 and 18, according to a report in The Guardian. Scientists found that 32.3 per cent were overweight or obese at age two, 22.3 per cent at age six, 24.7 per cent at age 10 and 20.6 per cent at age 14.
The findings were presented at the European Congress on Obesity in Malaga, Spain, where researchers stated that every one-unit increase in BMI at the age of six more than doubled the child's odds of being overweight or obese at 18.
"We need to understand how children grow and develop if we are to help future generations grow up healthier and give every child a chance at a happy, healthy life," said Jasmin de Groot of Erasmus MC, University Medical Centre Rotterdam.
"The first five years of a child's life provide a fantastic opportunity to intervene and prevent them experiencing overweight and obesity in the years to come."
The researchers highlighted that if a child with a higher BMI reached a healthy weight by the age of six, they were no longer at risk.
"Our research assists with this by showing that a child with overweight or obesity isn't destined to live with overweight or obesity as a young adult - and that the first five years of a child's life provide a fantastic opportunity to intervene and prevent them experiencing overweight and obesity in the years to come."
Additional research presented at the congress showed that ultra-processed foods such as packaged snacks and fizzy drinks, coupled with a sedentary lifestyle and excessive screen time, contributed to unhealthy weight in individuals.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Alzheimer's disease: A blood test can detect early symptoms, finds study
Alzheimer's disease: A blood test can detect early symptoms, finds study

Time of India

time21 hours ago

  • Time of India

Alzheimer's disease: A blood test can detect early symptoms, finds study

Imagine getting tested for Alzheimer's with just a simple blood draw instead of going through complicated brain scans or spinal taps. Sounds like the future, right? Well, it's pretty much here. Researchers at the Mayo Clinic in the U.S. have been working on a new blood test that can accurately detect early signs of Alzheimer's disease, and the results are seriously impressive. This test looks at two specific proteins in your blood—amyloid beta 42/40 and p-tau217—both of which are linked to that gunky buildup in the brain called amyloid plaques, a telltale sign of Alzheimer's. So how accurate is it? Try 95% sensitivity, meaning it correctly identifies people who do have memory problems 95% of the time. That's pretty hard to beat. It also has 82% specificity, which means it's also really good at ruling out people who don't have Alzheimer's. What's even better? This isn't just lab testing. The study was done on over 500 real patients in a memory clinic—so it's based on actual, day-to-day medical situations, not just controlled experiments. Dr. Gregg Day, who led the study (published in Alzheimer's & Dementia journal), said this new blood test works just as well as the more invasive and expensive options we currently use. "It's about as accurate as spinal fluid testing," he told The Guardian, 'but way easier, less painful, and much cheaper.' In people who had Alzheimer's, the levels of p-tau217 were clearly higher compared to those who didn't, which helped the team confirm the diagnosis confidently. The best part? This blood test has already gotten the green light from the U.S. FDA—so it's not just theory anymore, it's actually available. 6 million Americans are living with Alzheimer's disease Alzheimer's disease is becoming a huge concern across the U.S.—and it's not just about forgetfulness in old age. It's a progressive brain disorder that slowly chips away at memory, thinking skills, and the ability to do everyday tasks. Right now, more than 6 million Americans are living with Alzheimer's, and that number is expected to nearly double by 2050. Most people with Alzheimer's are 65 or older, but it can also hit younger adults in what's called early-onset Alzheimer's. The biggest risk factor is age, but family history and genetics also play a role. The disease usually starts slow—maybe forgetting names or getting lost in familiar places—and worsens over time. The best part is science is catching up. New blood tests and brain imaging tools are helping doctors catch the disease earlier than ever before. There are also a few new medications out that might slow down the progression if taken early enough. Next up, researchers want to test it on even more diverse groups of people and also those who might be in the very early stages of Alzheimer's but don't have any symptoms yet. In short: diagnosing Alzheimer's just got a whole lot simpler—and that could change everything when it comes to early intervention and treatment. One step to a healthier you—join Times Health+ Yoga and feel the change

FIFA World Cup 2026: How Thomas Tuchel's England are relying on a 60 pound pill and heat chambers in their World Cup campaign
FIFA World Cup 2026: How Thomas Tuchel's England are relying on a 60 pound pill and heat chambers in their World Cup campaign

Indian Express

time2 days ago

  • Indian Express

FIFA World Cup 2026: How Thomas Tuchel's England are relying on a 60 pound pill and heat chambers in their World Cup campaign

A 60 pound pill to track heat resistance in a player's body along with training in heat chambers is what the Thomas Tuchel coached England football team is undergoing in their FIFA World Cup 2026 qualification training programme. While England have won its opening two matches of the Group K in their FIFA World Cup 2026 qualification route, the team has spent a week in Girona, Spain this month to simulate extremely hot and humid conditions they could face in the 2026 World cup to be played in USA, Canada and Mexico. 'Using them (the tracking pill) in a training environment is lower risk than that. The players would be doing minimal contact either side of the heat acclimation sessions. It is very simple tech that has been around for quite a while. They are very accurate. They allow us to store more data than we actually need so you can sample body temperature between five and 30 seconds, and the download time is really quick. We can get a measure of core body temperature during activity,' Dr Lee Taylor, of the sports science school at Loughborough University, told The Guardian. While England team had practised heat acclimatisation prior to the 2022 World Cup in Qatar, where they reached the quarter-finals, it's the first time that the players are undergoing the fitness Tests including the tracking of heat resistance data. According to the BBC, there have been warnings that temperatures at 14 to 16 stadiums being used for the FIFA World Cup 2026 could exceed 'Potentially dangerous levels' during the tournament to be played from June 11 to July 19 next year. According to the Guardian, the pills send information on a radio frequency to be read in real time by sports scientists. The pills beam the data to a 'gateway'-a wristband in case of athletes-which uploads the data to -the cloud- from where data is accessible to analyse including a player's core and surface temperature, heart-rate and other crucial metrics. England players Eberechi Eze and Cole Palmer have talked about the training in heat chambers while their body reaction was measured via the pills. 'It was tough. It was 35C, 36C inside the tents and we had to get to a certain watts [level] on the bike and maintain it. For 45 minutes.' Palmer told The Guardian. According to the newspaper, the pulls have been used by athletes in athletics, rugby and motor racing. Taylor also talked about telling the players that 'they are not to retrieve them'. 'The players would be doing minimal contact either side of the heat acclimation sessions. It is very simple tech that has been around for quite a while. They are very accurate. They allow us to store more data than we actually need so you can sample body temperature between five and 30 seconds, and the download time is really quick. We can get a measure of core body temperature during activity. We do make it very clear to them that they are not to retrieve them', said Dr Taylor. Last week, Tuchel had spoken about the expected conditions at the 2026 World Cup venues. 'It is important to see matches now in America, and in Miami at three in the afternoon. I will see that. How it looks, and we need to understand how to cool the players down, to drink. What our options are. Let's see because it is after the season, so it will be very similar. The actual experience is for the players, but I have done pre-season there in Orlando and I will be very surprised if we do not suffer. Suffering is one of the headlines for this World Cup,' Tuchel told BBC. England now play Andorra at RCDE Stadium in Spain in their third Group K match in 2026 World Cup qualification. The team has won its last two matches sitting at the top of the group. Dr Taylor also talked about the training regime of the England team in the training camps. 'They (Tuchel and staff) will do technical and tactical work in a temperate environment. So they are not stressing the players too much and then they will give them passive or semi-active heat exposures. I imagine they are getting the players to a specific core temperature, they stop exercising and then when their core temperature drops they exercise a little bit more,' concluded Dr Taylor.

UK watchdog warns of pregnancy risks linked to weight-loss drugs
UK watchdog warns of pregnancy risks linked to weight-loss drugs

India Today

time2 days ago

  • India Today

UK watchdog warns of pregnancy risks linked to weight-loss drugs

Women are being advised to use effective contraception while on these medications. () UK health authorities recently cautioned against weight-loss drugs during pregnancy Mounjaro may reduce effectiveness of oral contraceptives Serious risks include acute pancreatitis with severe stomach pain Women using popular weight-loss and diabetes injections, also called "skinny jabs" are being warned to take extra care with contraception and pregnancy plans in the UK. Health authorities say these medicines should not be taken if you're pregnant, planning to get pregnant, or breastfeeding. If someone becomes pregnant while on these medicines, they should speak to a doctor immediately and stop using the medicine. This warning comes from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and includes well-known medicines like Ozempic, Mounjaro, Wegovy, Saxenda and Victoza. These drugs are known as GLP-1 receptor agonists, which help reduce hunger and control blood sugar levels by copying a natural hormone released after eating. Some newer medicines like Mounjaro act on a second hormone that also helps with appetite and blood sugar control. While they are approved for treating type 2 diabetes, and in some cases for weight loss, they are not meant for cosmetic or quick weight-loss purposes. The MHRA said Mounjaro may reduce the effectiveness of oral contraceptives such as the pill in people who are overweight, and that women taking the medication should use barrier contraceptives such as condoms, according to a report in The Guardian. The UK watchdog said it had received 26 pregnancy-related reports for Mounjaro. "These are powerful medications meant to treat serious medical conditions. They should not be used casually or bought from unregulated sources like beauty salons or social media," said Dr Alison Cave, Chief Safety Officer at MHRA. Women are being advised to use effective contraception while on these medications and in some cases for up to two months after stopping them. This is because there isn't enough data to confirm if these drugs are safe for the baby during pregnancy. Forms of contraception include: Oral contraceptives (the pill) Non-oral methods like condoms, the coil, or implants However, Mounjaro may reduce the effectiveness of oral contraceptives in people who are overweight. That means women using Mounjaro should also use a non-oral method of contraception, especially in the first four weeks of treatment or after a dose increase. Another rare but serious risk of GLP-1 medicines is acute pancreatitis, which is inflammation of the pancreas. A warning sign of this is severe stomach pain that moves to the back and doesn't go away. Anyone who feels this should get emergency medical help. The MHRA also reminds users: These medicines must be prescribed by a healthcare professional. Do not buy them online or from beauty clinics, it is illegal and dangerous. Talk to your doctor before starting the medicine to understand risks and benefits. Let your doctor know if you're using one of these medicines before any surgery. Report any side effects through the Yellow Card scheme, which collects safety information on medicines in the UK. The watchdog also warned against extracting leftover medicine from used syringes. Dispose of them safely after completing the recommended doses, the statement read. These reminders come amid rising concerns that many people may be misusing these injections without knowing the full risks, especially women who may become pregnant. Staying informed and cautious is key to using these medicines safely. Women using popular weight-loss and diabetes injections, also called "skinny jabs" are being warned to take extra care with contraception and pregnancy plans in the UK. Health authorities say these medicines should not be taken if you're pregnant, planning to get pregnant, or breastfeeding. If someone becomes pregnant while on these medicines, they should speak to a doctor immediately and stop using the medicine. This warning comes from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and includes well-known medicines like Ozempic, Mounjaro, Wegovy, Saxenda and Victoza. These drugs are known as GLP-1 receptor agonists, which help reduce hunger and control blood sugar levels by copying a natural hormone released after eating. Some newer medicines like Mounjaro act on a second hormone that also helps with appetite and blood sugar control. While they are approved for treating type 2 diabetes, and in some cases for weight loss, they are not meant for cosmetic or quick weight-loss purposes. The MHRA said Mounjaro may reduce the effectiveness of oral contraceptives such as the pill in people who are overweight, and that women taking the medication should use barrier contraceptives such as condoms, according to a report in The Guardian. The UK watchdog said it had received 26 pregnancy-related reports for Mounjaro. "These are powerful medications meant to treat serious medical conditions. They should not be used casually or bought from unregulated sources like beauty salons or social media," said Dr Alison Cave, Chief Safety Officer at MHRA. Women are being advised to use effective contraception while on these medications and in some cases for up to two months after stopping them. This is because there isn't enough data to confirm if these drugs are safe for the baby during pregnancy. Forms of contraception include: Oral contraceptives (the pill) Non-oral methods like condoms, the coil, or implants However, Mounjaro may reduce the effectiveness of oral contraceptives in people who are overweight. That means women using Mounjaro should also use a non-oral method of contraception, especially in the first four weeks of treatment or after a dose increase. Another rare but serious risk of GLP-1 medicines is acute pancreatitis, which is inflammation of the pancreas. A warning sign of this is severe stomach pain that moves to the back and doesn't go away. Anyone who feels this should get emergency medical help. The MHRA also reminds users: These medicines must be prescribed by a healthcare professional. Do not buy them online or from beauty clinics, it is illegal and dangerous. Talk to your doctor before starting the medicine to understand risks and benefits. Let your doctor know if you're using one of these medicines before any surgery. Report any side effects through the Yellow Card scheme, which collects safety information on medicines in the UK. The watchdog also warned against extracting leftover medicine from used syringes. Dispose of them safely after completing the recommended doses, the statement read. These reminders come amid rising concerns that many people may be misusing these injections without knowing the full risks, especially women who may become pregnant. Staying informed and cautious is key to using these medicines safely. Join our WhatsApp Channel

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store